Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00513383
Recruitment Status : Completed
First Posted : August 8, 2007
Last Update Posted : March 1, 2017
Brigham and Women's Hospital
Information provided by (Responsible Party):
Lori J. Wirth, MD, Massachusetts General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2010
  Actual Study Completion Date : October 2012
Wirth, L.J. Phase I Study of Panitumumab, Chemotherapy, and Intensity-modulated Radiotherapy (IMRT) for head and neck cancer (HNC). Abstract-No.6083 2007 ASCO Annual Meeting